{"nct_id":"NCT02462525","title":"Dose-Escalation Study of ABBV-838, an Antibody Drug Conjugate, in Subjects With Relapsed and Refractory Multiple Myeloma","status":"TERMINATED","status_verified_date":"2018-09","start_date":"2015-05-06","start_date_type":"ACTUAL","primary_completion_date":"2017-12-06","primary_completion_date_type":"ACTUAL","completion_date":"2017-12-06","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["ABBV"]}